I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Steroid Injections for Retinal Swelling Relief
Introduction
Intravitreal steroid injections deliver anti-inflammatory medication directly into the eye. Your retina specialist uses these treatments to reduce swelling in the retina, the light-sensitive tissue at the back of the eye. Retinal swelling, also called macular edema, can blur your central vision and make daily tasks difficult. Steroid injections help by calming inflammation at its source.
These treatments have been used in retina care for more than two decades. They remain an important tool when other therapies have not provided enough relief. Your retina specialist will determine whether a steroid injection is the right approach for your specific condition and medical history.
Many retinal conditions involve inflammation that damages delicate tissue. When blood vessels in the retina become inflamed, they can leak fluid into the surrounding tissue. This fluid buildup causes the macula, the central part of the retina responsible for sharp vision, to swell. Reducing this inflammation is essential for protecting your eyesight.
Steroids are among the most effective anti-inflammatory medications available. When placed inside the eye, they work directly at the site of the problem. This targeted delivery allows your retina specialist to use a very small amount of medication for a strong local effect.
Understanding Intravitreal Steroids
Steroids reduce inflammation by blocking the chemical signals that cause blood vessels to leak. They also reduce the production of substances called cytokines and prostaglandins that drive swelling. By quieting these inflammatory pathways, steroids help the retina dry out and return to its normal thickness.
When injected into the vitreous, the gel-like substance filling the eye, the medication spreads to reach the retina. Some formulations dissolve gradually, while others are designed as slow-release implants. The method of delivery affects how long the medication remains active in your eye.
Anti-VEGF medications, which block vascular endothelial growth factor, are typically the first treatment your retina specialist considers for macular edema. However, steroids work through a different mechanism. While anti-VEGF drugs target one specific pathway, steroids address multiple inflammatory pathways at once.
Research from the DRCR Retina Network has shown that steroid agents can produce a greater immediate reduction in retinal thickness compared to anti-VEGF medications (DRCR Retina Network, 2016). This makes steroids particularly valuable for patients whose swelling has not responded adequately to anti-VEGF treatment alone. Your retina specialist may recommend a steroid when a broader anti-inflammatory approach is needed.
Steroid injections are most frequently recommended for patients who have not responded well to anti-VEGF therapy. They may also be preferred for patients who find it difficult to maintain the frequent visit schedule that anti-VEGF treatment requires. Patients with inflammation-driven conditions such as uveitis are particularly strong candidates.
Your retina specialist will consider several factors before recommending a steroid injection. These include your eye pressure history, lens status, the specific condition being treated, and whether you have had prior steroid treatments. Patients who have already had cataract surgery may be especially well suited because one of the main side effects, cataract formation, is no longer a concern.
Types of Steroid Treatments
Ozurdex (dexamethasone implant) is a tiny rod-shaped device placed inside the eye during a brief office procedure. It slowly releases dexamethasone over a period of up to six months. The implant is biodegradable, meaning it dissolves on its own and does not need to be removed.
Ozurdex is approved by the FDA for treating macular edema following retinal vein occlusion, noninfectious uveitis affecting the back of the eye, and diabetic macular edema. Its gradual release design provides sustained medication delivery, which can reduce the number of office visits compared to repeated injections.
Iluvien (fluocinolone acetonide implant) is an even longer-acting option designed for chronic diabetic macular edema. This very small implant releases medication continuously for up to three years. It is typically reserved for patients whose swelling has not improved enough with other treatments.
In the FAME clinical trials, 34 percent of patients with chronic diabetic macular edema who received the fluocinolone acetonide implant gained significant vision improvement at three years, compared to about 13 percent of those who did not receive treatment (FAME Study Group, 2011). This sustained benefit makes Iluvien particularly useful for patients who need long-term inflammation control.
Triamcinolone acetonide, available as Kenalog (triamcinolone acetonide) or Triesence (triamcinolone acetonide), is given as a direct injection of steroid suspension into the eye. Unlike the implant-based options, triamcinolone is a liquid that disperses through the vitreous cavity. Its effects typically last two to three months.
Triamcinolone is one of the earliest intravitreal steroids used in retina care. Your retina specialist may choose this option for diagnostic purposes, as a bridge treatment, or when implant-based therapies are not suitable. It can also be combined with other procedures such as vitrectomy surgery.
Conditions Treated
Diabetic macular edema (DME) occurs when diabetes damages the small blood vessels in the retina, causing them to leak fluid into the macula. This is one of the leading causes of vision loss in people with diabetes. Steroid injections are an important second-line therapy when anti-VEGF injections have not adequately reduced the swelling.
Patients with chronic DME that persists despite multiple anti-VEGF treatments may benefit substantially from switching to or adding a steroid implant. Your retina specialist may consider this approach if your swelling has lasted longer than three months without meaningful improvement from initial therapy.
Retinal vein occlusion (RVO) happens when a vein carrying blood away from the retina becomes blocked. This blockage causes blood and fluid to leak into the retinal tissue, leading to swelling and vision loss. Both branch retinal vein occlusion and central retinal vein occlusion can cause significant macular edema.
Steroid implants have shown strong results in reducing macular edema from RVO. Clinical studies have demonstrated meaningful improvements in both retinal thickness and visual acuity in patients treated with dexamethasone implants for this condition (Haller, 2010). Your retina specialist may choose a steroid when inflammation plays a prominent role in your vein occlusion.
Uveitis is inflammation inside the eye that can affect the uvea, the middle layer of the eye wall. When uveitis affects the back of the eye, it is called posterior uveitis, and it can cause severe macular edema. Noninfectious uveitis responds particularly well to steroid therapy because the underlying problem is inflammatory.
Research has shown that eyes with uveitis-related macular edema experience the greatest improvement in visual acuity following intravitreal steroid treatment compared to other conditions (Retina, 2014). Steroid implants can provide months of continuous anti-inflammatory medication, reducing the frequency of flare-ups and the need for systemic immunosuppressive drugs.
Your retina specialist may also consider intravitreal steroids for other conditions involving retinal inflammation or swelling. These can include postsurgical macular edema that develops after cataract surgery, known as Irvine-Gass syndrome. Steroids may also help with certain cases of macular edema related to retinal dystrophies.
In some situations, your retina specialist may use triamcinolone acetonide during vitrectomy surgery to help visualize the vitreous and internal limiting membrane. This diagnostic use helps the surgeon identify and remove tissue that might otherwise be difficult to see during the procedure.
What to Expect During Treatment
Your retina specialist will perform a thorough eye examination before scheduling a steroid injection. This typically includes measuring your eye pressure, examining the retina with specialized imaging such as optical coherence tomography (OCT), and reviewing your medical history. These steps help ensure the treatment is appropriate for your situation.
You should inform your retina specialist about all medications you take, especially blood thinners. You do not typically need to stop blood-thinning medications for this procedure. You can eat and drink normally before your appointment, and you will not need general anesthesia.
The injection itself takes only a few minutes and is performed in the office. Your retina specialist will clean the area around your eye with an antiseptic solution to reduce the risk of infection. Numbing drops or a small injection of local anesthetic will be applied to minimize discomfort.
Using a very fine needle, your retina specialist will inject the medication or implant through the white part of the eye into the vitreous cavity. You may feel a brief sensation of pressure during the injection. Most patients describe the experience as mildly uncomfortable rather than severely painful. After the injection, your eye pressure may be checked before you leave the office.
You may notice some temporary blurriness, mild redness, or a feeling of something in your eye after the injection. These symptoms typically improve within a day or two. Your retina specialist may prescribe antibiotic eye drops to use for several days following the procedure.
You can usually return to most normal activities the same day, although you should avoid rubbing your eye. Your retina specialist will schedule a follow-up visit, typically within two to four weeks, to check your eye pressure and assess the early response to treatment. It is important to attend all follow-up appointments.
Benefits and Risks
One of the primary advantages of intravitreal steroids is their ability to address multiple inflammatory pathways simultaneously. This broad anti-inflammatory effect can be more effective than single-pathway treatments for certain patients. Steroid implants also provide sustained medication release, which may reduce the total number of injections needed over time.
Benefits of intravitreal steroid treatment include:
- Effective reduction of macular edema across multiple retinal conditions
- Longer duration of action compared to many anti-VEGF injections
- Particularly strong results in inflammation-driven conditions such as uveitis
- Reduced visit burden for patients who have difficulty with frequent appointments
- Useful alternative when anti-VEGF therapy has not provided adequate improvement
The two most common side effects of intravitreal steroid injections are elevated eye pressure and cataract development. Elevated intraocular pressure (IOP), the pressure inside the eye, occurs in a notable portion of patients. Studies show that about 28 percent of patients receiving dexamethasone implants experience an IOP increase of ten or more points above their baseline measurement (FDA, 2014). In most cases, this pressure increase is temporary and manageable with eye drops.
Cataract progression is the other significant consideration, particularly for patients who still have their natural lens. Over time, repeated steroid treatments can accelerate clouding of the lens. Your retina specialist will monitor for this and can coordinate cataract surgery if needed. Patients who have already undergone cataract surgery do not face this risk.
As with any injection into the eye, there is a small risk of infection called endophthalmitis. This is rare but serious, and your retina specialist takes careful steps to minimize this risk through sterile technique. Symptoms to watch for include increasing pain, worsening vision, or significant redness in the days following the injection.
Other uncommon side effects may include floaters, which are small spots or strands drifting in your vision, or temporary blurred vision as the medication settles. In rare cases, the implant may migrate to the front of the eye, particularly in patients who have had prior eye surgery. Your retina specialist will discuss your individual risk profile before proceeding with treatment.
Follow-Up Care
Regular monitoring of your eye pressure is one of the most important aspects of follow-up care after a steroid injection. Your retina specialist will check your IOP at each visit to detect any elevation early. Most pressure increases develop within the first few weeks to months following the injection and respond well to pressure-lowering eye drops.
If your eye pressure does rise, your retina specialist has several options for managing it. Topical medications are the first approach and are effective for the large majority of patients. Fewer than five percent of patients who receive steroid implants require a surgical procedure to control their eye pressure (FAME Study Group, 2011). Your retina specialist will work with you to find the right balance between treating your retinal condition and maintaining healthy eye pressure.
Your retina specialist will use OCT imaging to measure the thickness of your retina at follow-up visits. This scan creates a detailed cross-section of your macula, allowing your specialist to see whether the swelling is decreasing. Visual acuity testing will also track any changes in your ability to read letters on the eye chart.
The response to steroid treatment varies among patients. Some people notice improvement within the first few weeks, while others may take longer to see the full benefit. If the initial treatment provides good results but the swelling returns as the medication wears off, your retina specialist may recommend retreatment or a longer-acting implant option.
Managing chronic retinal conditions typically requires a long-term treatment plan. Your retina specialist may adjust your therapy over time based on how your eyes respond. This might involve switching between different types of steroids, combining steroids with anti-VEGF therapy, or changing the interval between treatments.
It is important to keep all scheduled appointments even if your vision feels stable. Retinal swelling can return without noticeable symptoms, and early detection allows your retina specialist to act before significant vision changes occur. Open communication about any new symptoms or concerns will help your specialist provide the best possible care.
When to See a Retina Specialist
After receiving a steroid injection, you should contact your retina specialist right away if you experience certain warning signs. These include a sudden decrease in vision, significant eye pain that worsens over time, increasing redness, or seeing new flashes of light. These symptoms could indicate a complication that needs prompt evaluation.
Warning signs to report to your retina specialist include:
- Sudden or worsening vision loss in the treated eye
- Increasing eye pain, especially beyond the first day after injection
- Heavy discharge or significant swelling of the eyelids
- New onset of flashing lights or a curtain-like shadow in your vision
- Sensitivity to light that does not improve
If you have a chronic condition such as diabetes, uveitis, or a history of retinal vein occlusion, regular visits with your retina specialist are essential for long-term eye health. Even between active treatment periods, routine monitoring can catch new episodes of swelling early. Early detection and treatment provide the best chance of preserving your vision.
Your retina specialist will recommend an appropriate follow-up schedule based on your condition and treatment history. For patients receiving long-acting implants like Iluvien, visits may still be needed every few months to monitor eye pressure and retinal health. Staying consistent with these appointments is one of the most important things you can do for your vision.
Frequently Asked Questions
The duration depends on the type of steroid used. Triamcinolone acetonide (Kenalog or Triesence) typically provides benefit for two to three months. Ozurdex (dexamethasone implant) releases medication gradually for up to six months. Iluvien (fluocinolone acetonide implant) can remain active for up to three years, making it the longest-lasting option currently available.
Many patients with chronic retinal conditions do require more than one treatment. Macular edema frequently recurs as the medication wears off, particularly with shorter-acting formulations. Your retina specialist will monitor your response and recommend retreatment if the swelling returns. The timing between treatments depends on which steroid is used and how your eye responds.
Yes, your retina specialist may combine steroid injections with other therapies. A common approach is to alternate between steroid and anti-VEGF injections, using each medication for its unique strengths. In some cases, a steroid implant may be placed at the same time as another procedure, such as retinal laser treatment, to provide both immediate and sustained benefit.
Elevated eye pressure is one of the more common side effects, but it is typically manageable. Your retina specialist will monitor your pressure at each follow-up visit. If it rises above a safe level, pressure-lowering eye drops are usually effective at bringing it back down. In most patients, the pressure increase is temporary and resolves as the steroid medication diminishes. Rarely, a minor procedure may be needed to manage the pressure.
Patients with a history of glaucoma or elevated eye pressure need careful evaluation before receiving intravitreal steroids. The risk of further pressure elevation is higher in these individuals. Your retina specialist will weigh the potential visual benefits against the risks and may consult with a glaucoma specialist. In some cases, shorter-acting steroids may be preferred so that any pressure elevation can be managed more quickly.
30 Years of Care & Commitment
